tiprankstipranks
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
Holding ASRT?
Track your performance easily

Assertio Therapeutics (ASRT) Financial Statements

1,075 Followers

Assertio Therapeutics Financial Overview

Assertio Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.722; its P/E ratio is -1.34; Assertio Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 29.20M$ 31.13M$ 32.45M$ 32.98M$ 35.63M
Gross Profit$ 21.65M$ 22.24M$ 21.27M$ 23.26M$ 28.57M
EBIT$ -2.12M$ -2.77M$ -3.62M$ -31.25M$ -228.24M
EBITDA$ 4.71M$ 4.05M$ 2.18M$ -26.35M$ -217.88M
Net Income Common Stockholders$ -2.92M$ -3.67M$ -4.51M$ -57.38M$ -279.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.58M$ 88.38M$ 80.74M$ 73.44M$ 76.89M
Total Assets$ 276.00M$ 279.44M$ 281.96M$ 286.42M$ 380.03M
Total Debt$ 38.84M$ 38.73M$ 38.62M$ 38.51M$ 38.87M
Net Debt$ -49.74M$ -49.65M$ -42.12M$ -34.93M$ -38.02M
Total Liabilities$ 145.48M$ 147.29M$ 147.47M$ 148.42M$ 187.16M
Stockholders Equity$ 130.52M$ 132.15M$ 134.49M$ 138.00M$ 192.87M
Cash Flow-
Free Cash Flow$ -35.00K$ 7.39M$ 7.51M$ 5.61M$ 2.58M
Operating Cash Flow$ -35.00K$ 7.39M$ 7.51M$ 5.71M$ 2.58M
Investing Cash Flow$ -6.71M$ -43.32M-$ -239.00K$ 4.14M
Financing Cash Flow$ -10.00K$ -75.00K$ -206.00K$ -8.91M$ -10.00K
Currency in USD

Assertio Therapeutics Earnings and Revenue History

Assertio Therapeutics Debt to Assets

Assertio Therapeutics Cash Flow

Assertio Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis